NOTICE OF INTENT TO SOLE SOURCE - Psomagen, Inc. GEM-X Cell QC, sequencing and data analysis
Special Notice monitored from sam-gov.
- Buyer / agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Notice type
- Special Notice
- Solicitation number
- PCA-NCI-09798
- Posted
- September 15, 2026
- Response deadline
- September 21, 2026
- Location
- MD, US
- Estimated value
- Not published by the source
- NAICS
- 541990
- Source
- sam-gov
Summary
Title: Psomagen, Inc. GEM-X Cell testing (ongoing studies) This is a Notice of Intent to Sole Source (NOI), not a request for proposal. The National Cancer Institute intends to negotiate on an other-than-full-and-open competition basis with Psomagen, Inc., 1330 Piccard Dr., Suite 103, Rockville, MD 20850-4372 for quality control of submitted single cell samples, generation of sequencing libraries with 10X Chromium GEM-X Single Cell 5p RNA, and expression analysis data of (fro…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.